IP vs NVAX · P/E 43, $26.62B cap vs P/E 2.5, rev $682.2M
International Paper (IP) versus Novavax Inc (NVAX) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Novavax Inc (NVAX) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported NVAX revenue for 2024-12-31 was $682.2M. Net income was -$187.5M. Revenue was down 30.7% from 2023-12-31 to 2024-12-31. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
IP currently screens at market cap $26.62B and trailing P/E 43.1. NVAX currently screens at market cap $1.09B and trailing P/E 2.5.
Not investment advice. Open the IP and NVAX stock pages for the full models.
Not investment advice.